Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab for radiation-induced cerebral edema after gamma knife treatment of brain metastases
ChiCTR2500107479Phase 4Recruiting
- Sponsor
- Xi'an International Medical Center Hospital
- Start
- Aug 2025
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, randomised trial of bevacizumab in cerebral edema and brain metastases (2 arms), sponsored by Xi'an International Medical Center Hospital. Primary endpoint: treatment response rate. Started Aug 2025; status: recruiting.
02
Drugs
bevacizumab
03
Conditions
cerebral edemabrain metastases
Beyond the preview
Go deeper on ChiCTR2500107479.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500107479.